Suchergebnisse - "IgG"

PubPharm (213)

21

CLEC5a-directed bispecific antibody for effective cellular phagocytosis

enthalten in: mAbs | 2022

von Kedage, V. | Ellerman, D. | Fei, M. | +9

22

Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species

enthalten in: mAbs | 2022

von Glover, Z. | Wecksler, A. | Aryal, B. | +7

23

A computational method for predicting the aggregation propensity of IgG1 and IgG4(P) mAbs in common storage buffers

enthalten in: mAbs | 2022

von Heads, J. | Kelm, S. | Tyson, K. | +1

24

The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa

in: mAbs | 2022

von Yuki Yamaguchi | Natsumi Wakaizumi | Mine Irisa | +10

25

Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometry

enthalten in: mAbs | 2021

von Lippold, S. | Knaupp, A. | de Ru, A. | +9

26

Highly sensitive detection of antibody nonspecific interactions using flow cytometry

enthalten in: mAbs | 2021

von Makowski, E. | Wu, L. | Desai, A. | +1

27

Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions : Experimental assessment and computational predictions of domain interactions

enthalten in: mAbs | 2021

von Lai, P. | Ghag, G. | Yu, Y. | +3

28

The therapeutic potential of sialylated Fc domains of human IgG

enthalten in: mAbs | 2021

von Pleass, R.

29

Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation

enthalten in: mAbs | 2021

von Wei, B. | Gao, X. | Cadang, L. | +19

30

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors

enthalten in: mAbs | 2021

von Wingert, S. | Reusch, U. | Knackmuss, S. | +13